%A Lukiw,Walter %A Andreeva,Tatiana %A Grigorenko,Anastasia %A Rogaev,Evgeny %D 2013 %J Frontiers in Genetics %C %F %G English %K Aging,Alzheimer’s disease (AD),amyloidogenesis,Inflammation,miRNA,neurotrophism,Presenilin,synaptogeneisis %Q %R 10.3389/fgene.2012.00327 %W %L %M %P %7 %8 2013-February-06 %9 Review %+ Dr Walter Lukiw,Louisiana State University Health Sciences Center,LSU Neuroscience Center and Departments of Neurology and Ophthalmology,New Orleans,70112,LA,United States,wlukiw@lsuhsc.edu %+ Prof Evgeny Rogaev,Vavilov Institute of General Genetics Russian Academy of Medical Science,Department of Genomics and Human Genetics,Moscow,119991,Russia,Evgeny.Rogaev@umassmed.edu %+ Prof Evgeny Rogaev,Brudnick Neuropsychiatric Research Institute, University of Massachusetts Medical School,Department of Psychiatry,Worcester,01605,MA,United States,Evgeny.Rogaev@umassmed.edu %+ Prof Evgeny Rogaev,Lomonosov Moscow State University,Faculty of Bioengineering and Bioinformatics,Moscow,Russia,Evgeny.Rogaev@umassmed.edu %# %! MicroRNA in Alzheimer’s disease %* %< %T Studying micro RNA Function and Dysfunction in Alzheimer’s Disease %U https://www.frontiersin.org/articles/10.3389/fgene.2012.00327 %V 3 %0 JOURNAL ARTICLE %@ 1664-8021 %X Alzheimer’s disease (AD) is a tragic, progressive, age-related neurological dysfunction, representing one of the most prevalent neurodegenerative disorders in industrialized societies. Globally, 5 million new cases of AD are diagnosed annually, with one new AD case being reported every 7 s. Most recently there has been a surge in the study of the regulatory mechanisms of the AD process, and the particular significance of small non-coding ∼22 ribonucleotide RNAs called micro RNAs (miRNAs). Abundant data have profiled miRNA patterns in healthy, aging brain, in mild cognitive impairment (MCI), and in the moderate- and late-stages of AD. The major mode of action of miRNA is to interact, via base-pair complementarity, with ribonucleotides located within the 3′ untranslated region (3′-UTR) of multiple target messenger RNAs (mRNAs), and in doing so decrease the capability of that specific mRNA to be expressed. Many miRNAs are highly cell- and tissue-specific. The human brain appears to use only a highly specific fraction of all known human miRNAs, whose speciation and complexity are defined as a discrete subset of all known small non-coding RNAs (sncRNAs) in the brain. In general, in contrast to normally, aging human brain, in AD a family of pathogenically up-regulated miRNAs appear to be down-regulating the expression certain brain-essential mRNA targets, including key regulatory genes involved interactively in neuroinflammation, synaptogenesis, neurotrophic functions, and amyloidogenesis. These up-regulated, NF-kB-sensitive miRNAs, involved in the innate immune and inflammatory response and synaptic, neurotrophic, and amyloidogenic functions include miRNA-9, miRNA-125b, miRNA-146a, and miRNA-155. Other miRNAs of the miRNA-15/107 family, miRNA-153 and miRNA-190, and others, will be discussed. Overall, this manuscript will review the known contribution of miRNAs to aging brain function and the role they appear to play in the incidence and progression of AD.